Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Neuropathic Pain in Fabry Disease
NCT01588314Phase 2Withdrawn
- Sponsor
- University of Minnesota
- Start
- Apr 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in neuropathic pain, sponsored by University of Minnesota. Planned start Apr 2012; status: withdrawn.
02
Drugs
gabapentin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01588314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01588314.